2024
DOI: 10.3892/etm.2024.12523
|View full text |Cite
|
Sign up to set email alerts
|

Selected markers of ovarian cancer and their relation to targeted therapy (Review)

Anna Markowska,
Zbigniew Kojs,
Damian Twardawa
et al.

Abstract: Despite advances in surgical treatment techniques and chemotherapy-including anti-angiogenic and immune poly (ADP-ribose) polymerase inhibitors, the 5-year survival rate in ovarian cancer (OC) remains low. The reasons for this are the diagnosis of cancer in advanced clinical stages, chemoresistance and cancer recurrence. New therapeutic approaches are being developed, including the search for new biomarkers that are also targets for targeted therapy. The present review describes new molecular markers with rele… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 49 publications
0
0
0
Order By: Relevance